Purified zymogens reveal mechanisms of snake venom metalloproteinase auto-activation
eLife · 2026
DOI: 10.7554/elife.109112 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2026. Verfasst von Sophie Hall und 17 weiteren Autor:innen. Beteiligte Einrichtung: School of Biochemistry, University of Bristol, Bristol, United Kingdom. Hauptthemen laut MEDLINE: Metalloproteases, Enzyme Precursors, Snake Venoms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, Wellcome Trust, UK Research and Innovation.
Abstract (Originalsprache)
Snake venoms contain diverse mixtures of toxins that evolved to incapacitate prey, but in humans, they cause extensive pathology following snakebite envenomation. In viper venom, some of the most potent toxins are the haemorrhagic and coagulopathic snake venom metalloproteinases (SVMPs). Because venoms contain an SVMP cocktail and due to their cytotoxicity, SVMP characterisations have been hampered by the lack of purified enzymes. By incorporating their prodomain, which blocks the active SVMP site, we overcame their cytotoxicity and enabled recombinant production of zymogens from all three structurally variable SVMP classes (PI, PII, and PIII) using our baculovirus/insect cell expression system. Zymogens were auto-activated by incubation with Zn 2+ ions, resulting in prodomain cleavage, PII disintegrin cleavage and PIII prodomain proteolysis. Auto-activated SVMPs were characterised using protein substrate degradation, platelet aggregation and blood coagulation assays, benchmarked to native venom-purified SVMP. Our recombinant zymogen production protocol is generically applicable for the expression of SVMPs, unlocking biomedical use in haematology and discovery of novel snakebite therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biochemistry, University of Bristol, Bristol, United Kingdom.
- Centre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
- Lancaster University, Lancaster, United Kingdom.
- Department of Biotechnology and Bioinformatics, Faculty of Chemistry, Rzeszow University of Technology, Rzeszow, Poland.
- Architecture et Fonction des Macromolécules Biologiques (AFMB), UMR 7257 CNRS-Aix-Marseille Université, Marseille, France.
ORCID-Profile: Sophie Hall, Iara Aime Cardoso, Srikanth Lingappa, Bronwyn Rand, Dakang Shen, Stefanie Kate Menzies, Alastair Poole, Nicholas R Casewell, Imre Berger, Christiane Schaffitzel
Förderung
- European Commission
- Wellcome Trust
- UK Research and Innovation
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Hall, S., Cardoso, I. A., Wilkinson, M. C., Carretero, M. M., Lingappa, S., Rand, B., Shen, D., Boldrini-França, J., Stenner, R., Menzies, S. K., Balchin, G., Hus, K. K., Vincentelli, R., Mumford, A., Poole, A., Casewell, N. R., Berger, I., & Schaffitzel, C. (2026). Purified zymogens reveal mechanisms of snake venom metalloproteinase auto-activation. eLife. https://doi.org/10.7554/elife.109112
Vancouver
Hall S, Cardoso IA, Wilkinson MC, Carretero MM, Lingappa S, Rand B, et al. Purified zymogens reveal mechanisms of snake venom metalloproteinase auto-activation. eLife. 2026. doi:10.7554/elife.109112
BibTeX
@article{Hall2026,
author = {Hall, Sophie and Cardoso, Iara Aime and Wilkinson, Mark C and Carretero, Maria Molina and Lingappa, Srikanth and Rand, Bronwyn and Shen, Dakang and Boldrini-França, Johara and Stenner, Richard and Menzies, Stefanie Kate and Balchin, Georgia and Hus, Konrad Kamil and Vincentelli, Renaud and Mumford, Andrew and Poole, Alastair and Casewell, Nicholas R and Berger, Imre and Schaffitzel, Christiane},
title = {Purified zymogens reveal mechanisms of snake venom metalloproteinase auto-activation},
journal = {eLife},
year = {2026},
doi = {10.7554/elife.109112}
}
EUVIMED